accountwas up for Food and Drug Administration review in 1998 when the company's partner at the time, Abbott Laboratories Inc, withdrew its application for approval amid fears that the drug might cause heart problems. In a memo released on Friday, the FDA's...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to WRAPUP 1-US sees death concern in schizophrenia drugs
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account